Skip to main content

Want a detailed portfolio tracker?

Altimmune (ALT) P/E (2011 - 2026)

Altimmune (ALT) P/E from Mar 31, 2011 to Jul 21, 2026. The TTM Altimmune (ALT) P/E is -2.95. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Altimmune (ALT)

YearP/EChange
2026-2.95-21.88%
2025-3.77-30.32%
2024-5.41-25.75%
2023-7.29-13.85%
2022-8.46+125.43%
2021-3.75-43.17%
2020-6.60+385.41%
2019-1.36+594.64%
2018-0.20-96.76%
2017-6.04-97.46%
2016-237.57-33.10%
2015-355.09+225.44%
2014-109.11+33.79%
2013-81.55-25.80%
2012-109.91-16.63%
2011-131.84N/A

Comparison Altimmune (ALT) P/E with competitors

Altimmune (ALT) P/E is -2.95.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.06%
NBYStablecoin Development Corp0.00-100.15%
ENLVEnlivex Ltd0.07-102.54%
FGENFibroGen Inc0.24-108.15%
CHRSCoherus Biosciences Inc0.85-128.81%
FBIOFortress Biotech Inc0.95-132.22%
ORMPOramed Pharmaceuticals Inc1.50-151.03%
AGENAgenus Inc3.01-202.18%
INVAInnoviva Inc3.15-207.08%
VXRTVaxart Inc3.55-220.51%
CRMDCorMedix Inc3.63-223.18%
CVACCureVac N.V.4.45-250.93%
GLPGGalapagos NV4.86-264.96%
SRPTSarepta Therapeutics Inc4.88-265.74%
ABEOAbeona Therapeutics Inc5.39-282.90%
ABUSArbutus Biopharma Corp5.60-289.97%
ZVRAZevra Therapeutics Inc5.89-299.87%
SPROSpero Therapeutics Inc6.23-311.45%
CGENCompugen Ltd6.31-314.36%
RIGLRigel Pharmaceuticals6.87-333.30%
SLXNSilexion Therapeutics Corp7.30-347.70%
OMEROmeros Corporation9.26-414.33%
AUPHAurinia Pharmaceuticals Inc9.58-425.41%
PLXProtalix BioTherapeutics Inc10.89-469.75%
ACADAcadia Pharmaceuticals Inc11.73-498.18%
TBPHTheravance Biopharma Inc12.26-516.30%
ADMAAdma Biologics Inc12.42-521.59%
HRMYHarmony Biosciences Holdings Inc13.82-569.19%
SABSSAB Biotherapeutics Inc14.14-579.92%
NAGENiagen Bioscience Inc14.82-603.07%
INCYIncyte Corp15.82-637.17%
REGNRegeneron Pharmaceuticals Inc15.86-638.33%
PBYIPuma Biotechnology Inc17.32-687.86%
CPRXCatalyst Pharmaceuticals Inc17.44-692.06%
EXELExelixis Inc17.54-695.41%
TGTXTG Therapeutics Inc18.97-743.89%
MDXGMimedx Group Inc20.55-797.75%
XOMAXOMA Royalty Corp22.87-876.61%
ARGXArgen X SE24.30-924.93%
CTMXCytomX Therapeutics Inc24.82-942.69%
XOMAOXOMA Royalty Corp25.34-960.47%
HALOHalozyme Therapeutics Inc25.62-969.94%
XOMAPXOMA Royalty Corp25.67-971.51%
VRTXVertex Pharmaceuticals Inc27.99-1050.44%
RPRXRoyalty Pharma plc - Class A28.69-1073.96%
SLNOSoleno Therapeutics Inc29.02-1085.09%
ASNDAscendis Pharma A/S30.09-1121.42%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1387.13%
APLSApellis Pharmaceuticals Inc39.02-1424.79%
BMRNBiomarin Pharmaceutical Inc42.21-1533.12%
KRYSKrystal Biotech Inc45.34-1639.44%
ONCBeiGene Ltd69.54-2460.94%
PHARPharming Group N.V.75.03-2647.16%
TECHBio-Techne Corp101.96-3561.55%
VCELVericel Corp109.92-3831.89%
ALNYAlnylam Pharmaceuticals Inc117.96-4104.98%
GMABGenmab140.29-4862.95%
TLXTelix Pharmaceuticals Ltd162.15-5605.18%
CORTCorcept Therapeutics Inc212.86-7326.64%